A Multicenter, Randomized, Double-blind, Phase II Study to Evaluate the Tolerability of an Induction Dose Escalation of Everolimus in Patients With Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Everolimus (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms Desiree
- 12 Dec 2015 Trial design presented at the 38th Annual San Antonio Breast Cancer Symposium.
- 06 Jul 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 17 Mar 2015 New trial record